(redirected from Stable Ischemic Heart Disease)
SIHDStable Ischemic Heart Disease (cardiology)
SIHDSummary-Institution Holdings Data
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
However, the guidelines still recommend aspirin, to be continued indefinitely in stable ischemic heart disease, and clopidogrel is only used if aspirin is contraindicated, Prof.
Most of these elderly patients need urological procedure before elective intervention for stable ischemic heart disease. There was increasing trend of CAD in female and young population in this study as predicted by INTERHEART study and reported by us in our previous study17,18.
Objective: To assess the current burden/frequency of chronic coronary total occlusions in patients with stable ischemic heart disease undergoing angiography at Army cardiac centre Lahore.
Clinical practice in this regard appears to be largely out of touch with current evidence-based guidelines regarding angina management in patients with stable ischemic heart disease. Those ACC/American Heart Association guidelines recommend a stepwise approach beginning with a beta-blocker and sublingual nitroglycerin, adding a calcium channel blocker if the beta-blocker isn't tolerated or effective, further adding a long-acting nitrate if symptoms persist, incorporating ranolazine (Ranexa) as needed, and finally turning to revascularization for symptomatic relief if multidrug therapy proves inadequate (J Am Coll Cardiol.
ISCHEMIA is a randomised controlled trial studying 8,000 patients with stable ischemic heart disease and moderate to severe ischemia.
Atherosclerotic plaque causing obstruction of the coronary arteries is the most common etiology of stable ischemic heart disease (IHD) [3].
The 2012 American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) guideline for the diagnosis and management of patients with stable ischemic heart disease (SIHD) recommended that CCTA can be useful for risk assessment in patients with SIHD, who have an indeterminate result from functional testing (Class IIa).
The BARI 2D trial was designed to learn whether patients with type 2 diabetes and stable ischemic heart disease benefit from prompt coronary revascularization plus intensive medical therapy, compared with intensive medical therapy alone.
2012 ACCF/AHA/ACP/AATS/PCNA/ SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the American College of Physicians American Association for Thoracic Surgery Preventive Cardiovascular Nurses Association Society for Cardiovascular Angiography and Interventions and Society of Thoracic Surgeons J Am Coll Cardiol.
Conclusion: ST-T resting maps are of some value in diagnosing stable ischemic heart disease.